Thermo Fisher Scientific
S&P 500
$609.82
+1.10%
Delayed · cached 15 min
Fair value analysis
TMO
Thermo Fisher Scientific
$609.82
Close used for this calculation
$302.62Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
46/100
Quality radar
Consensus fair value
$302.62
Above FV▼ -50.4% against the close used
Model range $227.25 – $354.80
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$227.25Fair value$302.62Bull$354.80
FairClose
52-week traded range
52W low $438.3452W high $639.45
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Thermo Fisher Scientific closed at $609.82, 101.5% above the consensus fair value of $302.62 drawn from 8 valuation models.
Financial DNA score 46/100 — Average. P/E of 34.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$330.53
-45.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$238.20
-60.9%
√(22.5 × EPS × BVPS)
EPS=17.74, BVPS=142.15 · outside Graham range (P/E 34.4, P/B 4.3) — asset-light, treat as a rough floor
P/E Fair Value
$354.80
-41.8%
EPS × 20x (sector P/E)
EPS=17.74, Sector P/E=20x
Peter Lynch (PEG)
$227.25
-62.7%
EPS × Growth% (PEG = 1 is fair)
EPS=17.74, g=12.8%
EV/EBITDA
$294.90
-51.6%
(EBITDA × 16.4x − Net Debt) ÷ Shares
EBITDA=8.8B
Book Value (P/B)
$239.17
-60.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=142.15, ROE=12.7%, g=6%, r=10%
Reverse DCF
$609.82
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 14.4% | Historical: 12.8%
Margin of Safety
$230.88
-62.1%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=307.84, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.